UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DC D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT TO~~Pursuant ~~SECTION~~to Section 13 ORor 15(d) OFof the Securities Exchange Act of 1934

~~THE SECURITIES~~Date ~~EXCHANGE~~of ~~ACT~~Report OF(Date ~~1934~~of earliest event reported): September 6, 2011(December 29, 2010)

Date of report (Date of earliest event reported): February 20, 2009

Aperture Health, Inc.

(Exact name of registrant as specified in its charter)

Nevada	000-09283	20-8085447
(State or Other Jurisdiction	(Commission File	(IRS Employer
of Incorporation)	Number)	Identification No.)

Nevada

(State of incorporation)

000-09283

(Commission File No.)

20-8085447

(IRS Employer

Identification No.)

27201 Puerta Real, Suite 350

Mission Viejo, CA 92691

(Address of ~~Principal~~principal ~~Executive~~executive ~~Offices)~~offices, ~~(Zip~~including ~~Code~~zip code)

949-609-1966

(Registrant’s telephone number, including area code)

~~(Former Name~~Check orthe ~~Former~~appropriate ~~Address,~~box below if ~~Changed~~the ~~Since~~Form ~~Last~~8-K ~~Report~~filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

~~Check~~¨ Written ~~the~~communications ~~appropriate~~pursuant ~~box below if the Form 8-K filing is intended~~ to ~~simultaneously~~ ~~satisfy~~Rule 425 ~~the~~under ~~filing obligation of~~ the ~~registrant~~Securities ~~under~~Act ~~any~~(17 ofCFR ~~the following provisions:~~230.425)

~~[ ] Written communications~~¨ Soliciting material pursuant to Rule 14a-12 ~~425~~ under the ~~Securities~~Exchange Act (17 CFR ~~230~~ 240.~~425~~14a-12)

~~[ ] Soliciting material~~¨ Pre-commencement communications pursuant to Rule ~~14a~~ 14d-122(b) under the Exchange Act (1717CFR ~~CFR~~ 240.~~14a~~14d-122(b))

~~[ ]~~ ¨ Pre-commencement communications pursuant to Rule ~~14d~~ 13e-24(bc) under the Exchange Act (17 CFR 240.~~14d~~13e-24(bc))

~~[ ] Pre-commencement communications~~SECTION ~~pursuant to Rule 13e~~1-~~4(c)~~ ~~under~~REGISTRANT'S ~~the~~BUSINESS ~~Exchange~~AND ~~Act (17 CFR 240.13e-4(c))~~OPERATIONS

Item 5 1.0201 –Entry ~~Departure~~into ofa ~~Directors~~Material orDefinitive ~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement.

On ~~February~~ 20December 29, ~~2009~~2010, ~~the~~Aperture ~~Company~~Health, ~~received~~Inc., a ~~letter~~Nevada ofcorporation ~~resignation~~(the ~~from~~“Registrant”) ~~Heidi Patterson,~~entered ~~Director,~~into ~~with~~an ~~due~~Agreement ~~effect~~and ~~from~~Plan ~~February~~of 20Share Exchange (“Exchange Agreement”) with Triad Therapeutics, ~~2009~~Inc., Msa Delaware corporation (“Triad”). Pursuant ~~Patterson informed~~to the ~~Company~~Exchange ~~that~~Agreement, ~~her~~51% ~~decision~~of tothe ~~resign~~Registrant’s ~~was~~then ~~not~~issued ~~the~~and ~~result~~outstanding common stock, or an aggregate of ~~any disagreement~~41,392,478 ~~with~~shares, were exchanged for all of the ~~Company~~then onissued ~~any~~and ~~matter~~outstanding ~~relating~~shares, toor ~~the~~an ~~Company’s operations~~aggregate of 25,215,118 ~~policies~~shares orof ~~practices~~common stock, of Triad.

~~Item 9.01. Financial Statements and Exhibits.~~Exhibit

~~None.~~Number Description

~~SIGNATURES~~10.1 Agreement and Plan of Share Exchange dated December 29, 2010.

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~SIGNATURE

~~APERTURE~~Pursuant ~~HEALTH,~~to ~~INC.~~the ~~By:~~requirements ~~/s/~~of ~~Thomas~~the ~~Banks~~Securities ~~Name:~~Exchange ~~Thomas~~Act ~~Banks~~of ~~Title:~~1934, ~~Chairman~~the ~~and~~Registrant ~~Chief~~has ~~Executive~~duly ~~Officer~~caused ~~Dated:~~this ~~February~~report ~~20,~~to ~~2009~~be signed on its behalf by the undersigned.

Dated: September 6, 2011

	APERTURE HEALTH, INC.


	By: /s/ Jim Hennig
	Name: Jim Hennig
	Title: President

Filing Compare · Aperture Health, Inc.